Jae-Hyun Park

Mr. Jae-Hyun Park

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in Nature
Verified
Journal Article
Open access
PDF file
JPJae-Hyun Park
Jae-Hyun Park
MIMasashi Iwamoto
Masashi Iwamoto
JYJi-Hye Yun
Ji-Hye Yun
TUTomomi Uchikubo-Kamo
Tomomi Uchikubo-Kamo
DSDonghwan Son
Donghwan Son
SPSam-Yong Park
Sam-Yong Park
Around 250 million people are infected with hepatitis B virus (HBV) worldwide1, and 15 million may also carry the satellite virus hepatitis D virus (HDV), which confers even greater risk of severe liver disease2. The HBV receptor has been identified as sodium taurocholate co-transporting polypeptide (NTCP), which interacts directly with the first 48 amino acid residues of the N-myristoylated N-terminal preS1 domain of the viral large protein3. Despite the pressing need for therapeutic agents to counter HBV, the structure of NTCP remains unsolved. This 349-residue protein is closely related to human apical sodium-dependent bile acid transporter (ASBT), another member of the solute carrier family SLC10. Crystal structures have been reported of similar bile acid transporters from bacteria4,5, and these models are believed to resemble closely both NTCP and ASBT. Here we have used cryo-electron microscopy to solve the structure of NTCP bound to an antibody, clearly showing that the transporter has no equivalent of the first transmembrane helix found in other SLC10 proteins, and that the N terminus is exposed on the extracellular face. Comparison of our structure with those of related proteins indicates a common mechanism of bile acid transport, but the NTCP structure displays an additional pocket formed by residues that are known to interact with preS1, presenting new opportunities for structure-based drug design.

22 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JYJi-Hye Yun
Ji-Hye Yun
XLXuanxuan Li
Xuanxuan Li
JYJianing Yue
Jianing Yue
JPJae-Hyun Park
Jae-Hyun Park
ZJZeyu Jin
Zeyu Jin
HLHaiguang Liu
Haiguang Liu
Significance: Light-driven rhodopsin proteins pump ions across cell membranes. They have applications in optogenetics and can potentially be used to develop solar energy–harvesting devices. A detailed understanding of rhodopsin dynamics and functions may therefore assist research in medicine, health, and clean energy. This time-resolved crystallography study carried out with X-ray free-electron lasers reveals detailed dynamics of chloride ion–pumping rhodopsin (ClR) within 100 ps of light activation. It shows the dissociation of Cl − from the Schiff base binding site upon light-triggered retinal isomerization. This Cl − dissociation is followed by diffusion toward the intracellular direction. The results hint at a common ion-pumping mechanism across rhodopsin families.

11 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NINaito Ishimoto
Naito Ishimoto
JPJae-Hyun Park
Jae-Hyun Park
KKKouki Kawakami
Kouki Kawakami
MTMichiko Tajiri
Michiko Tajiri
KMKenji Mizutani
Kenji Mizutani
SPSam-Yong Park
Sam-Yong Park
Neutrophil granulocytes play key roles in innate immunity and shaping adaptive immune responses. They are attracted by chemokines to sites of infection and tissue damage, where they kill and phagocytose bacteria. The chemokine CXCL8 (also known as interleukin-8, abbreviated IL-8) and its G-protein-coupled receptors CXCR1 and CXCR2 are crucial elements in this process, and also the development of many cancers. These GPCRs have therefore been the target of many drug development campaigns and structural studies. Here, we solve the structure of CXCR1 complexed with CXCL8 and cognate G-proteins using cryo-EM, showing the detailed interactions between the receptor, the chemokine and Gαi protein. Unlike the closely related CXCR2, CXCR1 strongly prefers to bind CXCL8 in its monomeric form. The model shows that steric clashes would form between dimeric CXCL8 and extracellular loop 2 (ECL2) of CXCR1. Consistently, transplanting ECL2 of CXCR2 onto CXCR1 abolishes the selectivity for the monomeric chemokine. Our model and functional analysis of various CXCR1 mutants will assist efforts in structure-based drug design targeting specific CXC chemokine receptor subtypes.

17 January 2024 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
JAJinta Asami
Jinta Asami
JPJae-Hyun Park
Jae-Hyun Park
YNYayoi Nomura
Yayoi Nomura
CKChisa Kobayashi
Chisa Kobayashi
JMJunki Mifune
Junki Mifune
UOUmeharu Ohto
Umeharu Ohto

6 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJae-Hyun Park
Jae-Hyun Park
KKKouki Kawakami
Kouki Kawakami
NINaito Ishimoto
Naito Ishimoto
TITatsuya Ikuta
Tatsuya Ikuta
MOMio Ohki
Mio Ohki
SPSam-Yong Park
Sam-Yong Park
Hydroxycarboxylic acid receptors (HCAR1, HCAR2, and HCAR3) transduce Gi/o signaling upon biding to molecules such as lactic acid, butyric acid and 3-hydroxyoctanoic acid, which are associated with lipolytic and atherogenic activity, and neuroinflammation. Although many reports have elucidated the function of HCAR2 and its potential as a therapeutic target for treating not only dyslipidemia but also neuroimmune disorders such as multiple sclerosis and Parkinson’s disease, the structural basis of ligand recognition and ligand-induced Gi-coupling remains unclear. Here we report three cryo-EM structures of the human HCAR2–Gi signaling complex, each bound with different ligands: niacin, acipimox or GSK256073. All three agonists are held in a deep pocket lined by residues that are not conserved in HCAR1 and HCAR3. A distinct hairpin loop at the HCAR2 N-terminus and extra-cellular loop 2 (ECL2) completely enclose the ligand. These structures also reveal the agonist-induced conformational changes propagated to the G-protein-coupling interface during activation. Collectively, the structures presented here are expected to help in the design of ligands specific for HCAR2, leading to new drugs for the treatment of various diseases such as dyslipidemia and inflammation.

25 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKaho Shionoya
Kaho Shionoya
JPJae-Hyun Park
Jae-Hyun Park
TEToru Ekimoto
Toru Ekimoto
JTJunko S. Takeuchi
Junko S. Takeuchi
JMJunki Mifune
Junki Mifune
Koichi WatashiKoichi Watashi
Koichi Watashi
Macaque restricts hepatitis B virus (HBV) infection because its receptor homologue, NTCP (mNTCP), cannot bind preS1 on viral surface. To reveal how mNTCP loses the viral receptor function, we here solve the cryo-electron microscopy structure of mNTCP. Superposing on the human NTCP (hNTCP)-preS1 complex structure shows that Arg158 of mNTCP causes steric clash to prevent preS1 from embedding onto the bile acid tunnel of NTCP. Cell-based mutation analysis confirms that only Gly158 permitted preS1 binding, in contrast to robust bile acid transport among mutations. As the second determinant, Asn86 on the extracellular surface of mNTCP shows less capacity to restrain preS1 from dynamic fluctuation than Lys86 of hNTCP, resulting in unstable preS1 binding. Additionally, presence of long-chain conjugated-bile acids in the tunnel induces steric hindrance with preS1 through their tailed-chain. This study presents structural basis in which multiple sites in mNTCP constitute a molecular barrier to strictly restrict HBV.